BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abe M, Yoshida T, Akiba J, Ikezono Y, Wada F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, Sata M, Koga H, Yoshimura A, Torimura T. STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury. World J Gastroenterol 2017; 23(37): 6833-6844 [PMID: 29085226 DOI: 10.3748/wjg.v23.i37.6833]
URL: https://www.wjgnet.com/1007-9327/full/v23/i37/6833.htm
Number Citing Articles
1
Jie Zhao, Xin Liu, Yao Chen, Lin-Shuang Zhang, Ya-Rong Zhang, Deng-Ren Ji, Shi-Meng Liu, Mo-Zhi Jia, Yong-Hong Zhu, Yong-Fen Qi, Feng-Min Lu, Yan-Rong Yu, De'Broski R. Herbert. STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal PathwayInfection and Immunity 2021; 89(3) doi: 10.1128/IAI.00309-20
2
Florence A. Servais, Mélanie Kirchmeyer, Matthias Hamdorf, Nadège W.E. Minoungou, Stefan Rose-John, Stephanie Kreis, Claude Haan, Iris Behrmann. Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3Molecular Therapy - Nucleic Acids 2019; 16: 419 doi: 10.1016/j.omtn.2019.03.007
3
Albert Caballeria-Casals, Marc Micó-Carnero, Carlos Rojano-Alfonso, Cristina Maroto-Serrat, Araní Casillas-Ramírez, Ana I. Álvarez-Mercado, Jordi Gracia-Sancho, Carmen Peralta. Role of FGF15 in Hepatic Surgery in the Presence of Tumorigenesis: Dr. Jekyll or Mr. Hyde?Cells 2021; 10(6): 1421 doi: 10.3390/cells10061421
4
Lorena Pantano, George Agyapong, Yang Shen, Zhu Zhuo, Francesc Fernandez-Albert, Werner Rust, Dagmar Knebel, Jon Hill, Carine M. Boustany-Kari, Julia F. Doerner, Jörg F. Rippmann, Raymond T. Chung, Shannan J. Ho Sui, Eric Simon, Kathleen E. Corey. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLDScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96966-5
5
Wajahat Mehal. NASH and HCC Are Driven by Different Signaling Pathways with a Common RegulatorCell Metabolism 2019; 29(1): 3 doi: 10.1016/j.cmet.2018.12.012
6
Yu Jiang, Qiu-Ju Han, Jian Zhang. Hepatocellular carcinoma: Mechanisms of progression and immunotherapyWorld Journal of Gastroenterology 2019; 25(25): 3151-3167 doi: 10.3748/wjg.v25.i25.3151
7
Lei Tang, Jin-Xia Liu, Zi-Juan Zhang, Chen-Zhou Xu, Xue-Ning Zhang, Wei-Rong Huang, Dan-Hua Zhou, Rong-Rong Wang, Xu-Dong Chen, Ming-Bing Xiao, Li-Shuai Qu, Cui-Hua Lu. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosisPathology - Research and Practice 2019; 215(6): 152386 doi: 10.1016/j.prp.2019.03.015
8
Hye Lee, Jinhyeok Choi, Taekwon Son, Eun Lee, Jeong‑Gyun Kim, Soo Ryu, Danbi Lee, Myoung Jang, Eunsil Yu, Young‑Hwa Chung, Irwin Gelman, Kyu‑Won Kim. A‑kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide‑induced liver injuryOncology Letters 2018;  doi: 10.3892/ol.2018.9396
9
Melanie J. Mittenbühler, Hans-Georg Sprenger, Sabine Gruber, Claudia M. Wunderlich, Lara Kern, Jens C. Brüning, F. Thomas Wunderlich. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinomaMolecular Metabolism 2018; 17: 122 doi: 10.1016/j.molmet.2018.08.010
10
Rodrigo Carlessi, Julia Köhn-Gaone, John K. Olynyk, Janina E. E. Tirnitz-Parker. Hepatocellular Carcinoma2019; : 69 doi: 10.15586/hepatocellularcarcinoma.2019.ch4